PATENT CLAIM ANALYSIS

Application Number: 16359958
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "289000"]

Abstract:
Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan.

Claim (Index 9):
The method of  claim 3 , wherein the dextromethorphan is orally administered in a dosage form that provides immediate release of the dextromethorphan.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 99.0
- Lexical Diversity: 1.45455
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15599163', '15621882', '15933075', '15688660', '15182253']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.904025584422502
- 35 USC 102 Novelty (BERT): 0.7047009048539014
- Combined Prediction Score: 0.8840931164656418
- Mean Citation Score: 725.0180499999999
- Max Citation Score: 727.90344
- Similarity Product: 580.6083460550022

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test